[1]BioorganicandMedicinalChemistryLetters,2008,vol.18,p.4388-4392
[1]Engers,DarrenW.;Frist,AudreyY.;Lindsley,CraigW.;Hong,CharlesC.;Hopkins,CoreyR.[BioorganicandMedicinalChemistryLetters,2013,vol.23,#11,p.3248-3252]
[1]Engers,DarrenW.;Frist,AudreyY.;Lindsley,CraigW.;Hong,CharlesC.;Hopkins,CoreyR.[BioorganicandMedicinalChemistryLetters,2013,vol.23,#11,p.3248-3252]
[2]CurrentPatentAssignee:CHENGDUZEPLETECH-CN105130991,2017,B
[1]BioorganicandMedicinalChemistryLetters,2013,vol.23,p.3248-3252
[1]Patent:CN105130991,2017,B
Title: Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.
Journal: Bioorganic & medicinal chemistry letters 20130601
Title: Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20080801